Physicians and patient advocates are sounding the alarm after the NIH abruptly withdrew a grant renewal application for the ...

In the phase III ARISE trial, adjunctive xanomeline and trospium chloride (Cobenfy) were no better than placebo at improving ...

Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater ...

While the most serious measles epidemic in a decade has led to the deaths of two children and spread to 27 states with no ...

In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

Catholics and Christians worldwide, as well as non-religious people, are mourning the death of Pope Francis, who is often ...

At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax's license by its April 1 ...

Many of them have close ties to HHS Secretary Robert F. Kennedy Jr., like Mikki Willis, the conspiracy filmmaker known for ...

The FDA will phase out petroleum-based food dyes in the coming months, FDA and HHS officials said Tuesday.

A bill introduced by Republicans in the Minnesota state legislature calls mRNA vaccines "weapons of mass destruction" and if ...

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...